Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SEBELIPASE ALFA vs SECUKINUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SEBELIPASE ALFA vs SECUKINUMAB: Safety Overview

Metric SEBELIPASE ALFA SECUKINUMAB
Total FAERS Reports 614 151,223
Deaths Reported 43 6,855
Death Rate 7.0% 4.5%
Hospitalizations 124 19,098
Average Patient Age 8.8 yrs 52.3 yrs
% Female Patients 51.3% 61.9%
Manufacturer Alexion Pharmaceuticals, Inc. Novartis Pharmaceuticals Corporation
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Prescription Prescription